Prolyl-Hydroxylase Inhibitors
"Prolyl-Hydroxylase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit the action of HYDROXYLASES that act on PROLINE to form HYDROXYPROLINE.
Descriptor ID |
D064800
|
MeSH Number(s) |
D27.505.519.389.740
|
Concept/Terms |
Prolyl-Hydroxylase Inhibitors- Prolyl-Hydroxylase Inhibitors
- Inhibitors, Prolyl-Hydroxylase
- Prolyl Hydroxylase Inhibitors
- Proline Dioxygenase Inhibitors
- Dioxygenase Inhibitors, Proline
- Inhibitors, Proline Dioxygenase
- Proline Hydroxylase Inhibitors
- Hydroxylase Inhibitors, Proline
- Inhibitors, Proline Hydroxylase
|
Below are MeSH descriptors whose meaning is more general than "Prolyl-Hydroxylase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Prolyl-Hydroxylase Inhibitors".
This graph shows the total number of publications written about "Prolyl-Hydroxylase Inhibitors" by people in this website by year, and whether "Prolyl-Hydroxylase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2019 | 1 | 0 | 1 |
2022 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prolyl-Hydroxylase Inhibitors" by people in Profiles.
-
The ASCEND-ND trial: study design and participant characteristics. Nephrol Dial Transplant. 2022 10 19; 37(11):2157-2170.
-
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial. Clin J Am Soc Nephrol. 2022 09; 17(9):1325-1336.
-
Debate: Are HIF Stabilizers a Viable Alternative to ESAs in the Management of Anemia in CKD? PRO. Am J Nephrol. 2022; 53(5):361-365.
-
Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease. Curr Opin Nephrol Hypertens. 2019 11; 28(6):600-606.